Trial NCT00827099

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000632453
Secondary IDs: BMTGG-NSH-801

Last trial update was posted on 2012-03-23

MeSH Interventions

Antilymphocyte Serum Fludarabine Fludarabine phosphate Melphalan Mycophenolic Acid Tacrolimus

MeSH Conditions

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Disorders Neoplasms, Plasma Cell Plasmacytoma Preleukemia Syndrome

Other Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Stopping Reasons

Unacceptable morbidity & mortality

Limitations And Caveats

This study was terminated early, therefore no additional data measures or outcomes are available.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID